Biopsys Medical Signs Agreement With Columbia/HCA Healthcare.IRVINE, Calif.--(BUSINESS WIRE)--Nov. 7, 1996--Biopsys Medical, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BIOP BIOP Baghdad International Airport BIOP Broadcast Inter-ORB Protocol BIOP Burst Idle Optical Protocol BIOP Basis of Issue Plan BIOP Bureau d'Information et d'Orientation Professionnelles (French) ) today announced that it has signed a Preferred Vendor Agreement with Columbia/HCA Healthcare Corp. (NYSE NYSE See: New York Stock Exchange :COL) for the sale of the Biopsys Mammotome breast biopsy Breast Biopsy Definition A breast biopsy is removal of breast tissue for examination by a pathologist. This can be accomplished surgically, or by withdrawing tissue through a needle. system throughout the Columbia network. Under the agreement, Biopsys will market and sell its Mammotome Biopsy System to Columbia's 600 plus hospitals, surgery centers and clinics nationwide. "This agreement reflects the desire of both organizations to work together in bringing the latest in breast cancer diagnosis technology to all Columbia facilities," said Scott Tremberth, vice president of Sales for Biopsys. "The Mammotome has enabled many of our patients to avoid surgical breast biopsy. Instead, they undergo a 30 minute outpatient procedure done through a three millimeter skin incision incision /in·ci·sion/ (in-sizh´un) 1. a cut or a wound made by cutting with a sharp instrument.incis´ional 2. the act of cutting. in·ci·sion n. 1. ," said Timothy E. Tully, M.D., a radiologist radiologist /ra·di·ol·o·gist/ (ra?de-ol´ah-jist) a physician specializing in radiology. Radiologist at Columbia's Hoffman Estates Hoffman Estates A village of northeast Illinois, a suburb of Chicago. Population: 49,700. Medical Center, located in the Chicago area. Biopsys Medical, Inc. is a leading developer, manufacturer and marketer of products for the diagnosis and management of breast cancer. Through its principal product, the Mammotome Biopsy System, the company offers a less-invasive, cost-effective alternative to open surgical biopsy. Except for the historical information contained herein, this press release contains forward looking statements that involve risks and uncertainties that could cause actual results to differ materially. These factors include the rate and extent of market acceptance of the Mammotome Biopsy System, competitive factors including the risk of price competition, and the ability of the company to manufacture the Mammotome Biopsy System in sufficient quantities and on a cost effective basis. CONTACT: Biopsys Medical Inc. Steve Naber, 714/460-7800 or Morgen-Walke Associates Inc. Jenifer Kirtland/Jon Squire/Doug Sherk 415/296-7383 or Elissa Grabowski/Emily Dupree 212/850-5600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion